Evaxion Biotech Appoints Marianne Søgaard as Chairwoman
17 déc. 2020 01h30 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S, a clinical-stage biotechnology company developing AI-driven immunotherapies to improve the lives of patients with cancer...
EU Boosts Evaxion’s Artificial Intelligence Vaccine Research
09 déc. 2020 06h00 HE
|
Evaxion Biotech
EIB signs €20 million (DKK 149 million) loan agreement with Danish research and development company Evaxion Biotech A/S.Evaxion will use financing for research and development into its proprietary...
Evaxion Biotech Announces Publication in Nature Communications Describing Improved Selection of Immunotherapy Targets
09 déc. 2020 05h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S, a clinical-stage AI-immunology company developing immunotherapies to improve the lives of patients with cancer and...
Evaxion Biotech Launches New AI Powered Platform, RAVEN, to Enable Faster Response to Emerging Viral Pandemics
01 oct. 2020 07h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies and vaccines, announces...
Evaxion Biotech Appoints Chair and Strengthens Board of Directors
30 juin 2020 09h51 HE
|
Evaxion Biotech
Appoints Kim Bjoernstrup as Chair, deeply experienced industry executiveAppoints Helen M. Boudreau to Board of Directors, veteran CFO and biopharma executive COPENHAGEN, Denmark, June 30, 2020 ...
Evaxion Biotech Appoints Industry Veteran Glenn S. Vraniak as Chief Financial Officer and Further Strengthens Senior Executive Team
30 oct. 2019 08h00 HE
|
Evaxion Biotech
COPENHAGEN, Denmark, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Evaxion Biotech, a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies to improve the lives of...